LITTLE FALLS, N.J.,
Nov. 1, 2013 /PRNewswire/
-- CANTEL MEDICAL CORP. (NYSE: CMN) announced today
that for the second consecutive year, it was named to the Forbes
list of the "100 Best Small Companies in America." The Company was
ranked number 67 on the Forbes 2013 list.
Cantel's President and CEO, Andrew
Krakauer stated, "We are pleased to have been recognized for
the success the Company has achieved both this year and over the
past five years. I share this honor with our 1,300 hardworking and
loyal employees. As a leader in the growing infection prevention
and control market, the Company has performed well despite the
difficult economic environment. We are optimistic that Cantel is
positioned for sustained growth in the future. Our entire
organization has a great sense of pride in providing the products,
services and the guidance to mitigate infection risks, improve
safety, and ultimately help save lives."
The Forbes rankings are based on one and five-year earnings
growth, sales growth and return on equity. To qualify, companies
must have sales between $5 million and $1
billion, and meet certain share price and other criteria.
Forbes also considers a company's stock performance with its
industry peers during the last year.
About Cantel Medical Corp.
Cantel Medical is a leading
global company dedicated to delivering innovative infection
prevention and control products and services for patients,
caregivers, and other healthcare providers which improve outcomes,
enhance safety and help save lives. Our products include
specialized medical device reprocessing systems for endoscopy and
renal dialysis, advanced water purification equipment, sterilants,
disinfectants and cleaners, sterility assurance monitoring products
for hospitals and dental clinics, disposable infection control
products primarily for dental and GI endoscopy markets, dialysate
concentrates, hollow fiber membrane filtration and separation
products, and specialty packaging for infectious and biological
specimens. Additionally, we provide technical service for our
products.
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These statements involve a number of risks and uncertainties,
including, without limitation, the risks detailed in Cantel's
filings and reports with the Securities and Exchange Commission.
Such forward-looking statements are only predictions, and actual
events or results may differ materially from those projected or
anticipated.
SOURCE Cantel Medical Corp.